ID

Description

Active Ingredients
Tranexamic Acid, Glutathione, Ascorbic Acid, Niacinamide, Magnesium
Gluconate, Phenylalanine.
Mode of Action
The combination of its ingredients creates potent antioxidant and anti-
inflammatory activity, with a melanocyte synthesis action inhibitory
effect and tyrosinase enzyme inhibition. It also causes depigmentation
through pheomelanin pathway acceleration and the biochemical
reduction of the deposited pigment.
Treatment Protocol
Apply an ampoule using transdermal treatment every 15 days.
Application Protocol
Cleanse the treatment area with a mild action product until no impurities
remain. Perform suitable asepsis through the treatment area. Apply
the contents of the MELINE 01 ID ampoule into the pigmented areas
using transdermal therapy. If the event of diffused melasma/cloasma
pigmentation in the skin, apply the content across the entire facial
surface. Lastly, apply MELINE 03 MOIST as a thin layer onto the skin
surface and use MELINE 04 B.B. Cream to provide suitable protection.